A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Clinical trial NCT02059564 · UNKNOWN
Trial details
- NCT number
- NCT02059564
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-10-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.